Philips Delivers Strong Order Intake, Comparable Sales Growth and Margin Expansion in Q1; 2026 ...
Order intake rose 6% and adjusted EBITA margin reached 9% as strong demand in North America and Europe offset tariff pressure.
- On Wednesday, Dutch healthcare technology group Philips reported first-quarter sales of €3.9 billion, a 4% increase exceeding expectations, with order intake growth of 6% driven by North America and Europe.
- Growth spanned all business segments led by Personal Health, while disciplined productivity initiatives delivered €126 million in savings, enabling an adjusted EBITA margin of 9.0% despite tariff and cost inflation headwinds.
- Philips reinforced its MedTech leadership with FDA clearance for AI-powered cardiology solutions; SmartHeart automates cardiac MR views in under 30 seconds, reducing breath holds by up to 75%.
- Management reiterated its full-year 2026 outlook, projecting comparable sales growth of 3% to 4.5% and adjusted EBITA margin of 12.5% to 13.0%, with free cash flow of €1.3 billion to €1.5 billion.
- Future projections incorporate known tariff impacts within an uncertain macro environment but exclude potential International Emergency Economic Powers Act refunds and costs from ongoing Philips Respironics-related proceedings, including Department of Justice investigation.
41 Articles
41 Articles
The Dutch company reported sales of €3.91 billion (US$4.57 billion) in the first quarter, compared with €4.10 billion in the same period of the previous year.
Despite global geopolitical unrest, Philips posted higher profits in the first quarter of this year than a year earlier. The health technology company received 6 percent more orders than in the same period last year. Demand from consumers and hospitals was particularly strong in North America and Europe. Philips generated €3.9 billion in revenue in the first three months of this year. This is less than in the first quarter of last year, when rev…
Philips increased its profit in the first quarter, despite geopolitical issues such as US import tariffs and high energy prices due to the war in the Middle East. The healthcare technology group sold more and benefited from earlier measures to reduce costs.
Dutch health-tech group Philips’ sales, margins beat estimates on order growth
May 6 (Reuters) – Dutch healthcare technology group Philips reported first-quarter revenues and margins above market expectations on Wednesday, with order intake growth helped by demand in North America and Europe. Sales at the group, which makes products ranging from toothbrushes to medical imaging systems, grew 4% on a comparable basis to 3.91 billion euros ($4.59 billion) in the quarter ended March 31. That resulted in adjusted earnings …
InsideNoVA.com
Philips profits double in first quarter
Philips said Wednesday its first-quarter profits had doubled, maintaining its sales forecasts as the Dutch electronics and medical device manufacturer seeks to turn the page on a scandal involving faulty sleep machines.
Philips' profit rose sharply last quarter despite higher import tariffs. The healthcare technology company sold more medical equipment and consumer products. Cost savings also helped to keep more profit.
Coverage Details
Bias Distribution
- 41% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
